Weight loss / kanker

Biosynchronous transdermal drug delivery for longevity, anti-aging, fatigue management, obesity, weight loss, weight management, delivery of nutraceuticals, and the treatment of hyperglycemia, Alzheimer'S disease, sleep disorders, Parkinson'S disease, AIDS, epilepsy, attention deficit disorder, nicotine addiction, cancer, headache and pain control, asthma, angina, hypertension, depression, cold, flu and the like

Hanya pengguna terdaftar yang dapat menerjemahkan artikel

Masuk daftar

FIELD OF THE INVENTION The present invention relates to transdermal devices and methods for controllable dispensing of a nutraceutical or an active substance such as a chemical substance, a medication, a drug, a stimulant or the like, to a human or other mammal for purposes of promoting longevity,

Biosynchronous transdermal drug delivery for longevity, anti-aging, fatigue management, obesity, weight loss, weight management, delivery of nutraceuticals, and the treatment of hyperglycemia, alzheimer's disease, sleep disorders, parkinson's disease, aids, epilepsy, attention deficit disorder, nicotine addiction, cancer, headache and pain control, asthma, angina, hypertension, depression, cold, flu and the like

Hanya pengguna terdaftar yang dapat menerjemahkan artikel

Masuk daftar

FIELD OF THE INVENTION The present invention relates to transdermal devices and methods for controllable dispensing of a nutraceutical or an active substance such as a chemical substance, a medication, a drug, a stimulant or the like, to a human or other mammal for purposes of promoting longevity,

Biosynchronous transdermal drug delivery for longevity, anti-aging, fatigue management, obesity, weight loss, weight management, delivery of nutraceuticals, and the treatment of hyperglycemia, alzheimer's disease, sleep disorders, parkinson's disease, AIDs, epilepsy, attention deficit disorder, nicotine addiction, cancer, headache and pain control, asthma, angina, hypertension, depression, cold, flu and the like

Hanya pengguna terdaftar yang dapat menerjemahkan artikel

Masuk daftar

FIELD OF THE INVENTION The present invention relates to transdermal devices and methods for controllable dispensing of a nutraceutical or an active substance such as a chemical substance, a medication, a drug, a stimulant or the like, to a human or other mammal for purposes of promoting longevity,

Biosynchronous transdermal drug delivery for longevity, anti-aging, fatigue management, obesity, weight loss, weight management, delivery of nutraceuticals, and the treatment of hyperglycemia, alzheimer's disease, sleep disorders, parkinson's disease, aids, epilepsy, attention deficit disorder, nicotine addiction, cancer, headache and pain control, asthma, angina, hypertension, depression, cold, flu and the like

Hanya pengguna terdaftar yang dapat menerjemahkan artikel

Masuk daftar

FIELD OF THE INVENTION The present invention relates to transdermal devices and methods for controllable dispensing of a nutraceutical or an active substance such as a chemical substance, a medication, a drug, a stimulant or the like, to a human or other mammal for purposes of promoting longevity,

Biosynchronous transdermal drug delivery for longevity, anti-aging, fatigue management, obesity, weight loss, weight management, delivery of nutraceuticals, and the treatment of hyperglycemia, alzheimer's disease, sleep disorders, parkinson's disease, aids, epilepsy, attention deficit disorder, nicotine addiction, cancer, headache and pain control, asthma, angina, hypertension, depression, cold, flu and the like

Hanya pengguna terdaftar yang dapat menerjemahkan artikel

Masuk daftar

FIELD OF THE INVENTION The present invention relates to transdermal devices and methods for controllable dispensing of a nutraceutical or an active substance such as a chemical substance, a medication, a drug, a stimulant or the like, to a human or other mammal for purposes of promoting longevity,

Preparation and administration of jojoba product for reducing weight, fat and blood lipid levels and for the prevention and treatment of cancer

Hanya pengguna terdaftar yang dapat menerjemahkan artikel

Masuk daftar

BACKGROUND OF THE INVENTION The present invention relates to a method for reducing fat and blood lipid levels in humans. Obesity is defined as a body mass index of greater than 30, whereas overweight is defined as having a body mass index of greater than 25. Approximately 19% Americans are obese,

Method of using beta-hydroxy-beta-methylbutyrate for reducing tumor growth rate

Hanya pengguna terdaftar yang dapat menerjemahkan artikel

Masuk daftar

The present invention relates to methods for the prevention and treatment of chronic inflammatory diseases, cancer, and involuntary weight loss. In the practice of the present invention patients are enterally administered HMB alone or alternatively in combination with eicosapentaenoic (20:5

Oxprenolol compositions for treating cancer

Hanya pengguna terdaftar yang dapat menerjemahkan artikel

Masuk daftar

TECHNICAL FIELD The present invention relates to oxprenolol compositions and uses thereof, including uses of the oxprenolol compositions for treating cancer. BACKGROUND Cancer is the second most common cause of death in the United States, exceeded only by heart disease. In the United States, cancer

Weight loss by inhibition of gastrokine

Hanya pengguna terdaftar yang dapat menerjemahkan artikel

Masuk daftar

BACKGROUND Gastrokine-1 (Gkn-1) is a stomach protein that protects the gastrointestinal (GI) tract. Previously this protein was designated AMP-18. SUMMARY Gkn-1 knockout mice (Gkn-1-/-) were generated. Recombinant Gkn-1 peptide antibodies were produced to investigate this protein and its role in the

Targeting tumor cells with chemotherapeutic agents conjugated to matriptase antibodies

Hanya pengguna terdaftar yang dapat menerjemahkan artikel

Masuk daftar

FIELD OF THE INVENTION The present invention relates to new immunoconjugates comprising an anticancer agent and a monoclonal antibody and use of such immunoconjugates for killing or inhibiting the growth of matriptase expressing cancer cells, including but not limited to those of multiple myeloma

Targeting tumor cells with chemotherapeutic agents conjugated to matriptase antibodies

Hanya pengguna terdaftar yang dapat menerjemahkan artikel

Masuk daftar

FIELD OF THE INVENTION The present invention relates to new immunoconjugates comprising an anticancer agent and a monoclonal antibody and use of such immunoconjugates for killing or inhibiting the growth of matriptase expressing cancer cells, including but not limited to those of multiple myeloma

Therapeutic use of d-methionine to reduce the toxicity of platinum-containing anti-tumor compounds

Hanya pengguna terdaftar yang dapat menerjemahkan artikel

Masuk daftar

BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to the use of protective agents in cancer chemotherapy in human and animal subjects. Protective agents are compounds that prevent, reduce, or otherwise ameliorate the toxic side effects of anti-cancer

Preparation and administration of jojoba product for reducing weight, fat and blood lipid levels

Hanya pengguna terdaftar yang dapat menerjemahkan artikel

Masuk daftar

BACKGROUND OF THE INVENTION The present invention relates to a method for reducing fat and blood lipid levels in humans. Obesity is defined as a body mass index of greater than 30, whereas overweight is defined as having a body mass index of greater than 25. Approximately 19% Americans are obese,

Leptin antagonist and methods of use

Hanya pengguna terdaftar yang dapat menerjemahkan artikel

Masuk daftar

CROSS REFERENCE TO RELATED APPLICATION This application claims priority under 35 U.S.C. .sctn.119(e) to U.S. Provisional Application No. 61/211,527, filed Mar. 31, 2009, which application is incorporated by reference herein in its entirety. FIELD OF INVENTION The invention relates to leptin

Methods of treatment with compounds having RAR.alpha. receptor specific or selective activity

Hanya pengguna terdaftar yang dapat menerjemahkan artikel

Masuk daftar

BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to the use of compounds which have specific or selective agonist like activity on RAR.sub..alpha. retinoid receptors for treatment of diseases and conditions which respond to treatment by such retinoids. More

weight loss/kanker

Preparation and administration of jojoba product for reducing weight, fat and blood lipid levels and for the prevention and treatment of cancer

Method of using beta-hydroxy-beta-methylbutyrate for reducing tumor growth rate

Oxprenolol compositions for treating cancer

Weight loss by inhibition of gastrokine

Targeting tumor cells with chemotherapeutic agents conjugated to matriptase antibodies

Targeting tumor cells with chemotherapeutic agents conjugated to matriptase antibodies

Therapeutic use of d-methionine to reduce the toxicity of platinum-containing anti-tumor compounds

Preparation and administration of jojoba product for reducing weight, fat and blood lipid levels

Leptin antagonist and methods of use

Methods of treatment with compounds having RAR.alpha. receptor specific or selective activity

Database tanaman obat terlengkap yang didukung oleh sains